PharmAla Biotech Contracts UK CDMO for ALA-002 Production
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class...
Tag : biotechnology
Future Origins Receives National Award for Green Chemistry from ACS
Drop-in Replacement Nalo™ Honored as Scientific Breakthrough for Environmental Benefit Future Origins has been named a winner of the of the 2025 Green Chemistry Challenge Award...
CS Analytical Expands Service Offering; Launches Gas Testing Analytical
In industries where product quality and patient safety depend on unseen infrastructure, Gas Testing Analytical will deliver specialized testing, sampling, and validation services for gases and utilities...
ClearSign Technologies Corporation Announces Changes to BOD
ClearSign Technologies Corporation (Nasdaq: CLIR) (“ClearSign” or the “Company”), an emerging leader in industrial combustion and sensing technologies that support decarbonization, improve operational and energy efficiency, enable...
PepGen Shifts Focus to DM1 Program After PGN-EDO51 Update
– PGN-EDO51 did not achieve target dystrophin levels in CONNECT1-EDO51 trial; Company to discontinue development of DMD programs – – PGN-EDO51 at 10 mg/kg was...
Trailhead Biosystems Names David Llewellyn as New CEO
Trailhead Biosystems Inc. (TrailBio.com), a biotechnology company pioneering the creation of iPSC-derived human cells at scale for drug discovery and cell therapy, is pleased to...
Global Health Innovators Recognized at Abu Dhabi Health Awards
Abu Dhabi Global Health Week (ADGHW) today honoured exceptional individuals and institutions from around the world whose innovative contributions are advancing the future of health....
Murata Unveils World’s First Metal Cell Fractionation Filter
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announced today that has successfully commercialized and mass produced “CELLNETTA,” the world’s first*1 metal cell fractionation filter designed...
Assembly Biosciences Doses First Participant in ABI-6250 Study
Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 Biomarker of ABI-6250 target...
METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer
METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22,...
Kezar Life Sciences to Present Zetomipzomib Update on Feb 27
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...
Sphere Fluidics Unveils Cyto-Mine Chroma, Early Access Open
Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Sphere Fluidics, a...
GC Cell-Bifarma Symposium Expands Immuncell-LC’s Global Reach
GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized...